Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis

被引：14
|
作者：
Castilla, J. [1 ,2 ]
Martinez-Baz, I. [1 ,2 ]
Navascues, A. [3 ]
Fernandez-Alonso, M. [4 ]
Reina, G. [4 ]
Guevara, M. [1 ,2 ]
Chamorro, J. [3 ]
Ortega, M. T. [5 ]
Albeniz, E. [6 ]
Pozo, F. [7 ]
Ezpeleta, C. [3 ]
机构：
[1] Inst Salud Publ Navarra, Pamplona, Spain
[2] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Network Biomed Res Ctr Epidemiol & Publ Hlth, Valencia, Spain
[3] Complejo Hosp Navarra, Pamplona, Spain
[4] Univ Navarra Clin, Pamplona, Spain
[5] Hosp Reina Sofia, Tudela, Spain
[6] Direcc Atenc Primaria, Navarre Hlth Serv, Pamplona, Spain
[7] WHO Natl Influenza Ctr Madrid, Ctr Nacl Microbiol, Inst Salud Carlos III, Majadahonda, Spain
来源：
EUROSURVEILLANCE | 2014年 / 19卷 / 06期
关键词：
D O I：
10.2807/1560-7917.ES2014.19.6.20700
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We estimate mid-2013/14 season vaccine effectiveness (VE) of the influenza trivalent vaccine in Navarre, Spain. Influenza-like illness cases attended in hospital (n=431) and primary healthcare (n=344) were included. The overall adjusted VE in preventing laboratory-confirmed influenza was 24% (95% CI: -14 to 50). The VE was 40% (95% CI: -12 to 68) against influenza A(H1)pdm09 and 13% (95% CI: -36 to 45) against influenza A(H3). These results suggest a moderate preventive effect against influenza A(H1)pdm09 and low protection against influenza A(H3).
引用
收藏
页码：15 / 21
页数：7
相关论文
共 50 条
  • [21] Influenza Vaccine Effectiveness in Preventing Severe Outcomes in Patients Hospitalized with Laboratory-Confirmed Influenza during the 2017-2018 Season. A Retrospective Cohort Study in Catalonia (Spain)
    Acosta, Lesly
    Soldevila, Nuria
    Torner, Nuria
    Martinez, Ana
    Ayneto, Xavier
    Rius, Cristina
    Jane, Mireia
    Dominguez, Angela
    VIRUSES-BASEL, 2021, 13 (08):
  • [22] Effectiveness of the influenza vaccine for preventing laboratory-confirmed influenza infections in outpatient immunocompromised adults, 2017-2018
    Kramer, Kailey Hughes
    Zimmerman, Richard K.
    Haggerty, Catherine L.
    Balasubramani, G. K.
    Nowalk, Mary Patricia
    Martin, Emily T.
    Gaglani, Manjusha
    Phillips, C. Hallie
    Belongia, Edward
    Chung, Jessie
    Silveira, Fernanda P.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [23] Seasonal Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza in Primary Care in Israel, 2016-2017 Season: Insights Into Novel Age-Specific Analysis
    Stein, Yaniv
    Mandelboim, Michal
    Sefty, Hanna
    Pando, Rakefet
    Mendelson, Ella
    Shohat, Tamy
    Glatman-Freedman, Aharona
    CLINICAL INFECTIOUS DISEASES, 2018, 66 (09) : 1383 - 1391
  • [24] Vaccine Effectiveness against Medically Attended Laboratory-Confirmed Influenza in Japan, 2011-2012 Season
    Suzuki, Motoi
    Minh, Le Nhat
    Yoshimine, Hiroyuki
    Inoue, Kenichiro
    Yoshida, Lay Myint
    Morimoto, Konosuke
    Ariyoshi, Koya
    PLOS ONE, 2014, 9 (02):
  • [25] Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season
    Mira-Iglesias, Ainara
    Lopez-Labrador, Fxavier
    Baselga-Moreno, Victor
    Tortajada-Girbes, Miguel
    Mollar-Maseres, Juan
    Carballido-Fernandez, Mario
    Schwarz-Chavarri, German
    Puig-Barbera, Joan
    Diez-Domingo, Javier
    EUROSURVEILLANCE, 2019, 24 (31) : 11 - 22
  • [26] Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results
    Pebody, R.
    Warburton, F.
    Ellis, J.
    Andrews, N.
    Potts, A.
    Cottrell, S.
    Johnston, J.
    Reynolds, A.
    Gunson, R.
    Thompson, C.
    Galiano, M.
    Robertson, C.
    Byford, R.
    Gallagher, N.
    Sinnathamby, M.
    Yonova, I.
    Pathirannehelage, S.
    Donati, M.
    Moore, C.
    de Lusignan, S.
    McMenamin, J.
    Zambon, M.
    EUROSURVEILLANCE, 2016, 21 (38) : 41 - 51
  • [27] Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014
    McNeil, S. A.
    Shinde, V.
    Andrew, M.
    Hatchette, T. F.
    Leblanc, J.
    Ambrose, A.
    Boivin, G.
    Bowie, W. R.
    Diaz-Mitoma, F.
    ElSherif, M.
    Green, K.
    Haguinet, F.
    Halperin, S.
    Ibarguchi, B.
    Katz, K.
    Langley, J. M.
    Lagace-Wiens, P.
    Light, B.
    Loeb, M.
    McElhaney, J.
    MacKinnon-Cameron, D.
    McCarthy, A. E.
    Poirier, M.
    Powis, J.
    Richardson, D.
    Semret, M.
    Smith, S.
    Smyth, D.
    Stiver, G.
    Trottier, S.
    Valiquette, L.
    Webster, D.
    Ye, L.
    McGeer, A.
    EUROSURVEILLANCE, 2014, 19 (09): : 16 - 21
  • [28] Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis
    Castilla, J.
    Navascues, A.
    Casado, I.
    Diaz-Gonzalez, J.
    Perez-Garcia, A.
    Fernandino, L.
    Martinez-Baz, I.
    Aguinaga, A.
    Pozo, F.
    Ezpeleta, C.
    EUROSURVEILLANCE, 2017, 22 (07): : 11 - 16
  • [29] Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season
    Wu, Shuangsheng
    Pan, Yang
    Zhang, Xinxin
    Zhang, Li
    Duan, Wei
    Ma, Chunna
    Zhang, Yi
    Zhang, Man
    Sun, Ying
    Yang, Peng
    Wang, Quanyi
    Ma, Jun
    VACCINE, 2018, 36 (38) : 5774 - 5780
  • [30] Vaccine Effectiveness Against Laboratory-Confirmed Influenza Hospitalizations Among Elderly Adults During the 2010-2011 Season
    Kwong, Jeffrey C.
    Campitelli, Michael A.
    Gubbay, Jonathan B.
    Peci, Adriana
    Winter, Anne-Luise
    Olsha, Romy
    Turner, Robert
    Rosella, Laura C.
    Crowcroft, Natasha S.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (06) : 820 - 827
12345